Page last updated: 2024-08-23

razoxane and mitolactol

razoxane has been researched along with mitolactol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, KW; Cavalli, F1
Davey, P; Tudhope, GR1
Ash, A; Borden, EC; Enterline, HT; Falkson, G; Laucius, JF; Lerner, H; Paul, AR; Rosenbaum, C1
Cummings, FJ; DeWys, W; Gelman, R; Glick, J; Tormey, DC1

Trials

2 trial(s) available for razoxane and mitolactol

ArticleYear
[New substances in oncologic therapy].
    Deutsche medizinische Wochenschrift (1946), 1978, Jul-07, Volume: 103, Issue:27

    Topics: Altretamine; Ancitabine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Mitolactol; Nitrosourea Compounds; Razoxane; Remission, Spontaneous; Tamoxifen; Time Factors; Vinca Alkaloids; Zinostatin

1978
Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.
    Cancer clinical trials, 1981,Fall, Volume: 4, Issue:3

    Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Menopause; Middle Aged; Mitolactol; Neoplasm Metastasis; Piperazines; Razoxane; Time Factors; Vincristine

1981

Other Studies

2 other study(ies) available for razoxane and mitolactol

ArticleYear
Anticancer chemotherapy.
    British medical journal (Clinical research ed.), 1983, Jul-09, Volume: 287, Issue:6385

    Topics: Alkylating Agents; Altretamine; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Etoposide; Humans; Mitobronitol; Mitolactol; Nitrosourea Compounds; Razoxane; Vinca Alkaloids

1983
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas.
    American journal of clinical oncology, 1982, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Drug Evaluation; Female; Humans; Male; Maytansine; Mesothelioma; Middle Aged; Mitolactol; Osteosarcoma; Oxazines; Piperazines; Prognosis; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms

1982